Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow Round 8 mm, Tablet with imprint "AP;016". It contains Chlorpheniramine maleate 4 mg; of Chlorpheniramine maleate[chlorpheniramine];. This belongs to the Histamine-1 receptor antagonist pharmacologic class. It is manufactured by Bryant Ranch Prepack. For details please contact your physician.
Basic Information
- Imprint
- AP;016
- Color
- Yellow
- Shape
- Round
- Size
- 8 mm
Drug Information
- Strength
- Chlorpheniramine maleate 4 mg;
- Dosage Form
- Tablet
- RxCUI
- 1363309
Pharmaceutical Classification
- Pharmacologic Class
- Histamine-1 receptor antagonist
Related Medications
Other drugs in the same class: Histamine-1 Receptor Antagonist
- ALLEGRAfexofenadine hydrochloride 180 mg;ORANGE • OVAL
- ALLEGRAfexofenadine hydrochloride 60 mg;ORANGE • OVAL
- Aller-chlorCHLORPHENIRAMINE MALEATE 4 mg;YELLOW • ROUND
- BanophenDIPHENHYDRAMINE HYDROCHLORIDE 25 mg;PINK • OVAL
- BanophenDIPHENHYDRAMINE HYDROCHLORIDE 50 mg;PINK • CAPSULE
- Carbinoxamine MaleateCARBINOXAMINE MALEATE 4 mg;WHITE • ROUND
- cetirizine hydrochlorideCETIRIZINE HYDROCHLORIDE 10 mg;WHITE • OVAL
- Cetirizine HydrochlorideCetirizine Hydrochloride 10 mg;WHITE • BULLET
- Cetirizine HydrochlorideCETIRIZINE HYDROCHLORIDE 10 mg;WHITE • RECTANGLE
- Cetirizine HydrochlorideCETIRIZINE HYDROCHLORIDE 5 mg;WHITE • ROUND
Ingredients
- Active Ingredients
- Chlorpheniramine maleate[chlorpheniramine];
- Inactive Ingredients
- D&c yellow no. 10;croscarmellose sodium;anhydrous dibasic calcium phosphate;magnesium stearate;microcrystalline cellulose;starch, corn;silicon dioxide;
Additional Information
- Manufacturer
- Bryant Ranch Prepack
- Status (Rx/OTC)
- Otc
- Brand Names
- Aller-Chlor, Chlor-Trimeton, Wal-finate
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.